Ibex Investors’s Axogen AXGN Stock Holding History

Ibex Investors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,757	Closed	-$283K	–	160
2018 Q1	$283K	Sell	7,757 -1,417	-15%	-$43.5K	0.23%	167
2017 Q4	$263K	Buy	+9,174	New	+$216K	0.15%	71

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ibex Investors's AXGN Position: Q2 2018 in Review

Ibex Investors sold out of Axogen (AXGN) in Q2 2018, closing a stake of 7,757 shares — an estimated $283K sold.

Ibex Investors first reported a position in AXGN in Q4 2017 and held it in 2 quarters. The position peaked at $283K in Q1 2018. 177 funds tracked by Wall St. Rank hold AXGN as of Q2 2018.

Ibex Investors reported no remaining Axogen position as of Q2 2018 after selling out during the quarter.
Ibex Investors sold 7,757 Axogen shares in Q2 2018, an estimated $283K.
Ibex Investors first reported a position in Axogen in Q4 2017 and held it in 2 quarters.
Ibex Investors's Axogen position peaked at $283K in Q1 2018.
177 funds tracked by Wall St. Rank held Axogen as of Q2 2018.

Based on Ibex Investors's 13F filing for Q2 2018, filed 14 Aug 2018.